Skip to main
BTSG

BTSG Stock Forecast & Price Target

BTSG Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 40%
Buy 60%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

BrightSpring Health is delivering impressive financial results, with a significant beat in both EBITDA and revenue in 1Q26. The company's strong performance in both Pharmacy Solutions and Provider Services segments highlights its capabilities and potential for growth in the home and community-based healthcare services market. With a diverse range of services and a strong balance sheet, BrightSpring is well-positioned to capture a significant share of the growing demand for home healthcare services.

Bears say

BrightSpring Health is a mature company, which has recently raised its guidance for 2026; however, the forecasted core EBITDA growth seems conservative compared to its strong first quarter results. The Pharmacy Solutions segment continues to grow and generate high margins, but the decline in Home and Community revenue is concerning. The drag from the IRA may impact overall revenue and EBITDA in 2026, but the company is well-equipped to overcome this challenge through its core business. The company's strong balance sheet and low leverage add to its stability and potential for future growth.

BTSG has been analyzed by 10 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 60% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of BrightSpring Health Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About BrightSpring Health Services Inc (BTSG) Forecast

Analysts have given BTSG a Buy based on their latest research and market trends.

According to 10 analysts, BTSG has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $59.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $59.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

BrightSpring Health Services Inc (BTSG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.